Clinical trials: Pharmacotherapy Optimization
Cancer, Neoplasm
Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors
The study enrolled advanced cancer participants with unresectable or metastatic disease who were refractory to or were not candidates for standard approved therapy.
- Trial name
- NCT04717375
- Testing
- SAR444881, Pembrolizumab, Cetuximab
- Where
- 18 sites in United States, Canada and 2 more
- Volunteers
- 125 people, healthy volunteers welcome
- Sponsor
- Sanofi
Smoking Cessation
Individualizing Pharmacotherapy for African American Smokers
Improving cessation outcomes for African American smokers through the use of novel, empirically-based strategies is a national health priority.
- Trial name
- NCT03897439
- Testing
- Nicotine patch, Varenicline Tartrate, Bupropion
- Where
- United States
- Volunteers
- 392 people, healthy volunteers welcome
- Sponsor
- University of Kansas Medical Center